Edition:
United Kingdom

Spire Healthcare Group PLC (SPI.L)

SPI.L on London Stock Exchange

253.60GBp
22 Jun 2018
Change (% chg)

6.00 (+2.42%)
Prev Close
247.60
Open
248.80
Day's High
257.00
Day's Low
248.60
Volume
800,712
Avg. Vol
2,706,266
52-wk High
362.10
52-wk Low
204.80

Summary

Name Age Since Current Position

Garry Watts

61 2017 Non-Executive Chairman of the Board

Justin Ash

2017 Chief Executive Officer, Executive Director

Peter Bamford

64 2017 Senior Independent Deputy Chairman of the Board

Daniel Toner

2015 General Counsel, Group Company Secretary

Peter Corfield

2015 Group Commercial Director

Jean-Jacques de Gorter

Group Medical Director

Neil McCullough

Group Development Director

Antony Mannion

2012 Director, Strategy and Investor Relations

Simon Rowlands

61 2014 Non-Executive Director

Adele Anderson

53 2016 Independent Non-Executive Director

Anthony Bourne

2014 Independent Non-Executive Director

Janet Husband

76 2014 Independent Non-Executive Director

Biographies

Name Description

Garry Watts

Mr. Garry Andrew Watts, FCA, MBE, is Non-Executive Chairman of the Board of the Company. Garry Watts joined the Group as Executive Chairman in 2011 before becoming Non-Executive Chairman between Admission and March 2016. He again served as Executive Chairman between March 2016 and June 2017 before resuming his Non-Executive Chairman role in July 2017. The Company does not consider Garry to be independent due to his previous executive role. A chartered accountant by profession and former partner at KPMG, Garry’s extensive business knowledge and leadership on other listed company boards, including SSL International plc and Celltech Group plc, has ensured a seamless transition from private to public for the Company. He has a deep understanding of the healthcare sector, having served as a member of the UK Medicines and Healthcare Products Regulatory Agency Supervisory Board for 17 years. Garry was also previously an executive director of Medeva plc, deputy chairman of Stagecoach Group plc and a non-executive director of Protherics plc.

Justin Ash

Mr. Justin Ash is Chief Executive Officer, Executive Director of the Company. Justin was previously chief executive of Oasis Dental Care between 2008 and 2017 before leading its sale to Bupa. Prior to this, he was managing director of Lloyds Pharmacy and has held several other senior retail positions including general manager of KFC in the UK/Ireland, and commercial director of Allied Domecq Spirits and Wines (Europe). Justin was previously a senior consultant with Bain and Company in London and Paris.

Peter Bamford

Mr. Peter Bamford is Senior Independent Deputy Chairman of the Board of the Company. Peter was chairman of Six Degrees Holdings Limited from 2011 to 2015 and a nonexecutive director of Rentokil Initial plc from 2006 until 2016. He was also a director of Vodafone Group plc from 1998 to 2006 where he held senior executive roles, including chief marketing officer, chief executive of Northern Europe, Middle East and Africa and chief executive of Vodafone UK. Prior to this, Peter held senior positions with WH Smith plc (being a director between 1995 and 1997), Tesco plc and Kingfisher plc. He has served on the boards of public companies for the last 21 years and has extensive experience in developing and growing businesses and brands internationally. Peter was also a director of PRS for Music Limited between 2008 and 2014, being their chairman from 2010.

Daniel Toner

Mr. Daniel Toner is General Counsel, Group Company Secretary of the Company. Daniel Toner joined Bupa Hospitals as head of legal in 2006 before being appointed General Counsel and Group Company Secretary upon Spire Healthcare’s formation in 2007 and is a solicitor by profession. He oversees all legal activity at Spire Healthcare, ensures compliance with statutory and regulatory requirements, and that decisions of the Board of Directors are realised. Daniel is also the Company’s Whistleblowing Officer. Daniel is a director of NHS Partners Network, an organisation that represents independent sector organisations that provide NHS services. Previously, he worked for international law firm Freshfields Bruckhaus Deringer, in industry and within the commercial directorate of the Department of Health.

Peter Corfield

Mr. Peter Corfield is Group Commercial Director of the Company. Peter Corfield joined Spire Healthcare in October 2015 as Group Commercial Director and has responsibility for delivering revenue growth through our payor groups and identifying new business opportunities. He was appointed Chief Commercial Officer in January 2018 with additional responsibility for business development across the hospital portfolio. Prior to joining Spire Healthcare, he held a number of senior executive and board roles within the financial services industry in the UK, most recently as managing director of Ageas Retail Direct. Prior to this, Peter worked for both Zurich Financial Services Group and Royal Bank of Scotland in various roles that covered Europe, Middle East and Japan.

Jean-Jacques de Gorter

Dr. Jean-Jacques de Gorter (JJ) is Group Medical Director of the Company. Dr Jean-Jacques de Gorter joined Bupa Hospitals as director of clinical services in 2005 before being appointed Spire Healthcare’s Group Medical Director in 2007. He is responsible for driving the Group’s clinical governance, compliance and quality strategy. Prior to joining Bupa he served as a medical director for NHS Direct. Jean- Jacques has also been a non-executive director at the Milton Keynes University Foundation Trust, chairing its Quality Committee. He graduated from Charing Cross and Westminster Medical School, practised in the UK, Australia and New Zealand and subsequently completed his MBA at Cranfield School of Management.

Neil McCullough

Mr. Neil McCullough is Group Development Director of the Company. Neil McCullough joined Spire Healthcare on its formation in 2007 as Hospital Director at Spire Cambridge Lea Hospital before joining the executive team in 2011. In his role, Neil oversees Spire Healthcare’s business development strategy both at the local hospital level and corporately. Following an early career in accounting and finance, Neil moved into healthcare in 1993 working with Bupa UK Membership, where he held a number of senior sales and relationship management roles. He joined the Bupa Hospitals business in 1998, holding hospital general manager roles in both Birmingham and East Anglia. Neil then moved into preventative healthcare with Bupa Wellness in 2002, where, as sales director, he led the rapid expansion of the business for five years.

Antony Mannion

Mr. Antony Mannion is Director, Strategy and Investor Relations of the Company. Antony Mannion joined Spire Healthcare as Investor and Public Relations Director in March 2012, having spent seven years at SSL International plc, until its acquisition by Reckitt Benckiser Group plc in 2010, as group legal director and head of acquisitions. Prior to SSL International plc, Antony worked as a corporate lawyer at Freshfields in London and Paris, then as an investment banker at Citicorp in London and New York, and at Standard Chartered in Singapore. Antony has a wide range of experience in all areas of corporate finance, and has worked on significant acquisition and IPO transactions in both the UK and overseas.

Simon Rowlands

Mr. Simon Rowlands is Non-Executive Director of the Company, since June 2014. Simon’s extensive knowledge of the Company and its markets, combined with his wise counsel over a number of years, were among the reasons he was asked to continue to serve as a member of the Board following Cinven’s sale of their shareholding in 2015. He was a founding partner of the private equity firm Cinven until 2013, establishing and leading its healthcare team, and then served as a senior adviser until 2017. Simon founded a new private equity firm in 2016 focused on healthcare and consumer sectors of Sub Sahara Africa. Prior to joining Cinven, he worked with an international consulting firm on multidisciplinary engineering projects in the UK and southern Africa.

Adele Anderson

Ms. Adele Anderson is Independent Non-Executive Director of the Company. Adèle has gained extensive financial experience throughout her career and has significant knowledge of audit committees. Until July 2011, she was a partner in KPMG LLP and held a number of senior roles across their business including chief financial officer of KPMG UK, chief executive officer of KPMG’s captive insurer and chief financial officer of KPMG Europe. Adèle was a member of the board of trustees of Save the Children UK until December, 2017.

Anthony Bourne

Mr. Anthony Rhys Bourne (Tony) is Independent Non-Executive Director of the Company, since June 2014. Tony brings considerable knowledge of the healthcare industry to his role, having been chief executive of the British Medical Association for nine years until 2013. Prior to this, he was in investment banking for over 25 years, including as a partner at Hawkpoint and as global head of the equities division and a member of the managing board of Paribas. Tony has also previously served as a non-executive director of Bioquell Plc, Southern Housing Group, and the charity, Scope.

Janet Husband

Dame Janet Husband is Independent Non-Executive Director of the Company. Having trained in medicine at Guy’s Hospital Medical School, Dame Janet’s extensive career in healthcare allows her to bring invaluable insight and knowledge of the healthcare industry. She has previously served as a specially appointed commissioner to the Royal Hospital Chelsea, was president of the Royal College of Radiologists, chaired the National Cancer Research Institute in the UK and was a non- executive director of Nuada Medical Group. Dame Janet was appointed as Professor of Diagnostic Radiology at the University of London, Institute of Cancer Research, in addition to more than 30 years as a practising consultant radiologist at the Royal Marsden Hospital.